CAMBRIDGE, MA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)TO ENCOURAGE THE BUILDING AND STRENGTHENING OF COLLABORATIVE WORKING RELATIONSHIPS AMONGST LIFE SCIENCE INDUSTRY LEADERS IN A GLOBAL CONTEXT; PROMOTE CONTINUED INVESTMENT AND GROWTH IN THE LIFE SCIENCES; TO REVIEW EXCITING NEW OPPORTUNITIES FOR FUTURE INVESTMENT AND INNOVATION.
DUE TO COVID-19, THE ORGANIZATON WAS UNABLE TO HOLD ITS ANNUAL RETREAT IN 2021.TYPICALLY, THE ORGANIZATION HOLDS AN ANNUAL RETREAT THAT BRINGS TOGETHER LEADERS FROM THE BIOTECHNOLOGY AND...
DUE TO COVID-19, THE ORGANIZATON WAS UNABLE TO HOLD ITS ANNUAL RETREAT IN 2021.TYPICALLY, THE ORGANIZATION HOLDS AN ANNUAL RETREAT THAT BRINGS TOGETHER LEADERS FROM THE BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES. THE RETREAT PROVIDED STRUCTURED FORUMS WHERE PARTICIPANTS ENGAGE IN MEETINGS AND DISCUSSIONS REGARDING THE ADVANCEMENT OF SCIENCE, INDUSTRY TRENDS AND URGENT ISSUES.REGISTRATION AND SPONSORSHIP FEES FOR THE RETREAT THAT WERE PAID IN ADVANCE WERE DONATED BACK TO THE ORGANIZATION BY MOST PARTICIPANTS. REFUNDS DUE AND REGISTRATION FEES DEFERRED TO FUTURE EVENTS HAVE BEEN REMOVED FROM INCOME AND RECORDED AS LIABILITIES.PROGRAM SERVICE EXPENSES WERE INCURRED IN MANAGING THE RETREAT FOR THE 2020 & 2021 EVENT AND ADVANCE PLANNING FOR THE POSSIBILITY OF A 2022 EVENT.
DUE TO A REDUCTION IN REVENUES RESULTING FROM COVID-19 RESTRICTIONS, THE ORGANIZATION WAS UNABLE TO FUND SCHOLARSHIPS DURING FY 2021 AS THEY HAVE DONE IN PREVIOUS YEARS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2020 | 2019 | Change | |
|---|---|---|---|
| Revenue | N/A | $195,515 | -1.0% |
| Expenses | $78,668 | $160,481 | -0.5% |
| Net Income | N/A | $35,034 | N/A |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| PAUL SEKHRI | DIRECTOR | 0.50 |
Director
|
$0 | $0 | $0 |
| JEAN-PIERRE SOMMADOSSI | DIRECTOR | 0.50 |
Director
|
$0 | $0 | $0 |
| HELMUT SCHEUHSLER | DIRECTOR | 0.50 |
Director
|
$0 | $0 | $0 |
| STELIOS PAPADOPOULOS | DIRECTOR | 0.50 |
Director
|
$0 | $0 | $0 |
| HODA ABOU-JAMRA | PRESTREASCLERK DIRECTOR | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2021 | No data | $78,668 | $119,770 | No data |
| 2020 | $195,515 | $160,481 | $216,949 | $35,034 |
| 2019 | $237,780 | $341,502 | $216,263 | $-103,722 |
| 2018 | $322,250 | $343,797 | $375,475 | $-21,547 |
Compare THE BIOEXEC INSTITUTE INC with other nonprofits in Massachusetts and across the country.